Avricore Health Statistics
Total Valuation
Avricore Health has a market cap or net worth of 5.59 million. The enterprise value is 5.19 million.
| Market Cap | 5.59M |
| Enterprise Value | 5.19M |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 101.29M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.60% |
| Owned by Institutions (%) | n/a |
| Float | 92.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.05 |
| PB Ratio | 6.02 |
| P/TBV Ratio | 6.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.44 |
| EV / Sales | 3.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -30.59 |
Financial Position
The company has a current ratio of 17.92
| Current Ratio | 17.92 |
| Quick Ratio | 15.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.10% and return on invested capital (ROIC) is -26.61%.
| Return on Equity (ROE) | -86.10% |
| Return on Assets (ROA) | -23.12% |
| Return on Invested Capital (ROIC) | -26.61% |
| Return on Capital Employed (ROCE) | -62.26% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 26 |
| Asset Turnover | 0.88 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.11% in the last 52 weeks. The beta is 0.19, so Avricore Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +42.11% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 51.46 |
| Average Volume (20 Days) | 116,105 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Avricore Health had revenue of 1.38 million and -1.17 million in losses. Loss per share was -0.01.
| Revenue | 1.38M |
| Gross Profit | 599,855 |
| Operating Income | -578,107 |
| Pretax Income | -1.17M |
| Net Income | -1.17M |
| EBITDA | -414,984 |
| EBIT | -578,107 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 388,941 in cash and n/a in debt, with a net cash position of 388,941.
| Cash & Cash Equivalents | 388,941 |
| Total Debt | n/a |
| Net Cash | 388,941 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 928,577 |
| Book Value Per Share | 0.01 |
| Working Capital | 435,989 |
Cash Flow
In the last 12 months, operating cash flow was -105,326 and capital expenditures -64,388, giving a free cash flow of -169,714.
| Operating Cash Flow | -105,326 |
| Capital Expenditures | -64,388 |
| Free Cash Flow | -169,714 |
| FCF Per Share | n/a |
Margins
Gross margin is 43.48%, with operating and profit margins of -41.91% and -84.73%.
| Gross Margin | 43.48% |
| Operating Margin | -41.91% |
| Pretax Margin | -84.73% |
| Profit Margin | -84.73% |
| EBITDA Margin | -30.08% |
| EBIT Margin | -41.91% |
| FCF Margin | n/a |
Dividends & Yields
Avricore Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.09% |
| Shareholder Yield | 2.09% |
| Earnings Yield | -20.91% |
| FCF Yield | -3.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Avricore Health has an Altman Z-Score of 89.42 and a Piotroski F-Score of 3.
| Altman Z-Score | 89.42 |
| Piotroski F-Score | 3 |